» Articles » PMID: 36726972

Subgroup Dominant Microbiomes Are Associated with Divergent Cervicovaginal Immune Responses in a Longitudinal Cohort of Kenyan Women

Abstract

Most cervicovaginal microbiome-immunology studies to date have relied on 16S rDNA microbial profiling which does not resolve the molecular subgroups of , believed to be central to the pathogenesis of bacterial vaginosis (BV) and subsequent risk of HIV acquisition. Here we used the 60 universal target which in addition to other microbial taxa, resolves four subgroups, for cervicovaginal microbial profiling in a longitudinal cohort of Kenyan women to examine associations with cellular and soluble markers of inflammation and HIV susceptibility. Participants (N = 41) were sampled, contributing 362 samples for microbiome analysis. All non- dominant microbial communities were associated with high pro-inflammatory cytokine levels. Divergent associations were observed among different subgroup dominated communities with respect to the chemokine IP-10. Specifically, subgroup A dominant and polymicrobial communities were associated with reduced concentrations of IP-10 in adjusted linear mixed models (p<0.0001), compared to microbial communities dominated by (non-iners) species. However, these associations did not translate to significant differences in the proportion or absolute number of CCR5, HLA-DR and CD38 expressed on cervical CD4 T- cells. These findings suggest that some associations between subgroup dominant microbiomes and mucosal immunity differ and are relevant for the study of BV-pathogenesis and understanding the mechanisms of BV-associated HIV risk.

Citing Articles

Association between changes in genital immune markers and vaginal microbiome transitions in bacterial vaginosis.

Foessleitner P, Cooley Demidkina B, El-Arar W, Goldenberg M, Murthy M, Bergerat A Sci Rep. 2025; 15(1):3536.

PMID: 39875510 PMC: 11775339. DOI: 10.1038/s41598-025-88208-9.


Vaginal Bacteria and Proinflammatory Host Immune Mediators as Biomarkers of Human Immunodeficiency Virus Acquisition Risk Among African Women.

Srinivasan S, Richardson B, Wallis J, Fiedler T, Strenk S, Hoffman N J Infect Dis. 2024; 230(6):1444-1455.

PMID: 39248500 PMC: 11646615. DOI: 10.1093/infdis/jiae406.


Bacterial vaginosis-driven changes in cervicovaginal immunity that expand the immunological hypothesis for increased HIV susceptibility.

MacLean F, Tsegaye A, Graham J, Swarts J, Vick S, Potchen N bioRxiv. 2024; .

PMID: 39005354 PMC: 11245000. DOI: 10.1101/2024.07.03.601916.


Biofilm-Forming Capacity and Drug Resistance of Different Subgroups Associated with Bacterial Vaginosis.

Qin H, Liu Y, Zhai Z, Xiao B Microorganisms. 2023; 11(9).

PMID: 37764030 PMC: 10534620. DOI: 10.3390/microorganisms11092186.

References
1.
Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O . Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2018; 129(2):875-886. PMC: 6355215. DOI: 10.1172/JCI124473. View

2.
Vancuren S, Dos Santos S, Hill J . Evaluation of variant calling for cpn60 barcode sequence-based microbiome profiling. PLoS One. 2020; 15(7):e0235682. PMC: 7347135. DOI: 10.1371/journal.pone.0235682. View

3.
Nugent R, Krohn M, Hillier S . Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991; 29(2):297-301. PMC: 269757. DOI: 10.1128/jcm.29.2.297-301.1991. View

4.
Cohen C, Lingappa J, Baeten J, Ngayo M, Spiegel C, Hong T . Bacterial vaginosis associated with increased risk of female-to-male HIV-1 transmission: a prospective cohort analysis among African couples. PLoS Med. 2012; 9(6):e1001251. PMC: 3383741. DOI: 10.1371/journal.pmed.1001251. View

5.
Muzny C, Taylor C, Swords W, Tamhane A, Chattopadhyay D, Cerca N . An Updated Conceptual Model on the Pathogenesis of Bacterial Vaginosis. J Infect Dis. 2019; 220(9):1399-1405. PMC: 6761952. DOI: 10.1093/infdis/jiz342. View